Skip to main content
. 2016 Mar 21;23:13003–13014. doi: 10.1007/s11356-016-6389-7

Table 4.

Concentrations of pharmaceutical compounds in hospital wastewater treatment plants in Saudi Arabia (ng/L)a

Class Compound LOQb HWWTP1 HWWTP1 HWWTP2 HWWTP2
Inf. Eff. Inf. Eff.
Analgesics Paracetamol 0.5 12400 ± 340 73 ± 11 12300 ± 180 157 ± 20
Antidepressants Carbamazepine 0.25 151 ± 13 41 ± 1 73 ± 14 n/d
β-blockers Atenolol 5.0 730 ± 82 46 ± 2 329 ± 28 55 ± 4
Lipid regulators Bezafibrate 0.1 n/d n/d n/d n/d
Anesthetics Lidocaine 1.0 158 ± 12 114 ± 4 129 ± 6 <LOQ
Antibiotics Ciprofloxacin 2.5 5600 ± 660 n/d 2180 ± 250 n/d
Clarithromycin 0.5 83 ± 72 22 ± 9 38 n/d
Sulfamethoxazole 1.0 30 ± 7 n/d 132 ± 5 n/d
Erythromycin 0.5 n/d n/d n/d n/d
Metabolite of sulfamethoxazole NACS 5.0 1200 ± 55 59 ± 14 506 ± 21 n/d
Cytostatic Cyclophosphamide 1.0 n/d n/d n/d n/d
Others Caffeine 2.5 74,800 ± 15,500,502 n/d 27,500 ± 2000 n/d

n/d not detected

aEach sample was analyzed in triplicate. Results are reported as mean ± standard deviation (n = 3)

bLimit of quantitation (substances detected but not quantifiable); n/d = not detected